chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe upper arm pain and weakness of arm, inability to raise arm for two days, now cannot raise arm above head, past 90 * upward motion. Inability to lift, pull upward, or push without severe pain.
diagnosed with type A flu.; Initial information received on 06-Dec-2022 regarding an unsolicited valid non-serious case received from a patient via Social Media.  This case involves a patient of unknown age and gender who was diagnosed with type a flu after receiving Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect Influenza vaccine produced by unknown manufacturer (dose, strength, formulation, lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient was diagnosed with type A flu (influenza) (unknown latency) following the administration of Influenza vaccine.  No lab data reported.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
nausea, headache, dizziness, near syncope, tachycardia (130-150s), temperature of 101.4 All lasted around 6 hours and left as quickly as they came
was administered to a 5 month old patient; No additional AE reported; This spontaneous report was received from a pharmacist concerning a 5-month-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.   On an unspecified date, at 5 months-old, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) for prophylaxis (dose, route of administration, injection anatomical location, lot # and expiration date were not provided) (Product administered to patient of inappropriate age).  No additional adverse events were reported (No adverse event).
As the MA was leaving the room after giving the Gardasil and Flu vaccines, sister ran out of the room stating that her brother needed help.  MA went straight back in and found him "passed out"  / slumping to the floor.  Mother and MA report that he had a "tremor" and had a couple of tonic-clonic beats of his arms (but not legs / was standing up though and slumping, so legs might have been missed).  Mother got hold of him and put in in supine position on the exam table. He was observed for 30 minutes after the event and vital signs remained stable.  He returned to completely normal within a couple of minutes.  Tonic-clonic movements lasted on a few seconds (less than 20 seconds).  +sibling with known seizure disorder, so referral neurology was ordered
This spontaneous report as received from a registered nurse refers to a 4 month old patient. The patient's concurrent conditions, medical history and drug allergies were not reported. On 20-DEC-2016, the patient was vaccinated with improperly stored ROTATEQ, oral, (dose not reported) from lot # M007311 (expiry date: unspecified) for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information is not expected as all correspondence has been received. Follow-up information indicated that suspect product with the lot# M007311 had not actually involved in the previously reported temperature excursion. Therefore, case # 1612USA012636 is being deleted from our files on generic rotavirus vaccine, live, oral, pentavalent. Sender's Comments: US-009507513-1610USA008140: US-009507513-1610USA014705: US-009507513-1610USA014706.
11:45 AM: vaccination administered and syringe and needle malfunctioned mid-injection. Patient received 0.2 mL of vaccination, remaining 0.3 mL were wasted due to the malfunction. Patient and medical personnel administering the vaccine were not injured. Lead RN determined that the patient should receive another full dose of the vaccine. An additional 0.5 mL were administered. No adverse reactions reported, VAERS filed.
Tongue felt "funny",  tingling around the throat, tongue.   this started after about 15 minutes and persisted for 10-15 minutes.  we gave her 25mg oral diphenhydramine and the symptoms resolved.  No further symptoms.
51days from first vaccination; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (51days from first vaccination) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (51days from first vaccination). At the time of the report, PRODUCT DOSE OMISSION ISSUE (51days from first vaccination) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication history not provided. Treatment information was unknown
terribly sick; terrible headache; aches started/ Everything was hurting; her left arm where she got the vaccine, under her arm, her lymph nodes swelled to the size of a little kid's ball; Part of her left breast near the swollen lymph node was sore; back was hurting; couldn't even sleep with her ankles together in bed because she was hurting; couldn't even sleep with her ankles together in bed because she was hurting; low grade fever/ feeling feverish; congestion; This is a spontaneous report from a contactable nurse (patient).  A 57-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at age of 56-years, at single dose in left arm on 05Apr2021 11:30 (Lot Number: ER8735) for covid-19 immunisation.  The patient medical history was not reported. Historical Vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) also at age of 56-years, at single dose in left arm on 15Mar2021 13:45 (Lot Number: EP7534) for covid-19 immunisation. The patient had no side effects from the first covid-19 vaccine.   Concomitant medications included ongoing estradiol and atenolol; montelukast sodium (SINGULAIR); ongoing rosuvastatin calcium.  The patient reported that her side effects were terrible. She felt fine after her vaccine but that night on 05Apr2021, she became terribly sick. She had a terrible headache. Then aches started. In her left arm where she got the vaccine, under her arm, her lymph nodes swelled to the size of a little kid's ball, liked a toddler sized ball. She was sure it was the lymph node. Part of her left breast near the swollen lymph node was sore. It was just really terrible. Her back was hurting. Everything was hurting. She couldn't even sleep with her ankles together in bed because she was hurting. She was totally miserable. She also had a low-grade fever. She thought she would feel better the next day but her symptoms went on the whole week. As far as she could tell her symptoms were over on 10Apr2021. By 10Apr2021, she didn't feel bad anymore and the lymph nodes under her arm had gone down. And she had been taking Tylenol (took 2 tablets almost every time) and different things for her headache and feeling feverish. She had to take something for her aches. She had no idea her symptoms were going to continue that long. She also took Mucinex because she had congestion and she wanted to try and dry herself up. She had called her primary care doctor and was told to go to the emergency room but she never went. She was already miserable enough, she didn't want to sit in the emergency room. The patient did not take vaccines and probably hadn't had a vaccine since she was a teenager and that was a long time ago. She has no known allergies to medications. It was reported that the adverse events did not result in a visit to Emergency room or Physician Office. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The outcome for event congestion was recovering, while for remains event was recovered on 10Apr2021.  No follow-up attempts are needed. No further information is expected.
HARD LUMP AT INJECTION SITE; FELT SICK; SWELLING AT INJECTION SITE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On 2021, the subject experienced swelling at injection site. On 2021, the subject experienced hard lump at injection site. On 2021, the subject experienced felt sick. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt sick on 2021, and was recovering from swelling at injection site, and hard lump at injection site. This report was non-serious.
This spontaneous report was received from a medical assistant regarding a 9 week old female patient with no pertinent medical history and no drug reactions or allergies. On 12-JUL-2013 the patient was vaccinated with the first and only dose ROTATEQ (lot number and expiration date not reported) (oral, dose not reported). No other suspect therapies or concomitant medications were reported. The medical assistant reported that the patient vomited immediately after being administered the ROTATEQ dose. It was reported that the patient was in the office when this occurred. The outcome for vomiting was reported as recovered on 12-JUL-2013. No treatment was given for the above mentioned event. No laboratory diagnostic studies were performed. The reporter did not assess the causality between ROTATEQ and vomiting. Additional information has been requested.
Began experiencing severe headaches along with heart rate increase from normal (44) to over 100 on or around November 20th 2021. Also my blood pressure increased to 160/100 for weeks until I was seen by the cardiologist and prescribed Norvasc (Amlodipine) to reduce high blood pressure.
went to the hospital because he passed out from low blood pressure; went to the hospital because he passed out from low blood pressure; pneumonia; was dehydrated; This is a spontaneous report from Pfizer-sponsored program. A contactable 73-year-old male consumer received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 02Feb2021 via an unspecified route of administration, at single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. The patient went to the hospital because he passed out from low blood pressure. He was scheduled for his second dose on 17Feb2021, but he never made it to his second appointment because he was in the hospital. He was in rehab now. It was almost 6 weeks. The patient felt ok after getting the shot, but that night his son found him on the floor and took him to the hospital. It turned out he had pneumonia, low blood pressure and was dehydrated. The outcome of the events was unknown at the time of report.  Information on lot/batch number has been requested.
First symptoms were chest tightness and pain. The following three days, the left side of chest was tender to the touch and I had tightness in chest anytime I tried to take a deep breath. Heavy feeling in chest and pain. The next few days the pain subsided slightly and to this day, still have little pings of pain in area where heart is located.
After patient received vaccines he developed a rash which he initially developed itch to the throat and around the eyes. Patient then developed a mild itch that intensified to the body. Patient was given BENADRYL 5g po then followed by epinephrine 0.3 sq. Observed patient for 2 hrs and improved.
Papular rash on right hip, thorax and L inner arm since Friday (4 days) Claritin or OTC antihistamine PRN recheck if not better in one week
Admitted to hospital telemetry unit via ambulance late in the evening of 10/29/08. Patients chief complaint: chest pain. Troponin levels normal. No further information is available at this time.
Information has been received from a 61 year old female patient with osteoporosis, hypothyroidism and gastroparesis who on 24-OCT-2008 was vaccinated with ZOSTER (Oka/Merck) (Lot number was not available, therapy route, site unknown).  Concomitant therapy included SYNTHROID, DOMPERIDONE, TRAZODONE HC1, aspirin, calcium (unspecified) (+) vitamin D, FORTEO and ACIPHEX.  On 25-OCT-2008, one day after receiving ZOSTER (Oka/Merck), the patient experienced rash and redness on the injection site and headache.  She did not seek medical attention.  Subsequently, the patient fully recovered from all of the symptoms 5 days after experiencing those symptoms.  Additional information has been requested.
PATIENT DESCIRBED MUSCLE ACHES AND JOINT PAIN ABOUT 2 DAYS AFTER RECEIVING INITIAL DOSE OF GARDASIL ON 3/8/07. PATIENT CONTINUED WITH BODY ACHES AND JOINT PAIN UP UNTIL APRIL 6TH PATIENT REPORT THIS ON DATE 2ND INJECTION WAS TO BE GIVEN ON 4/20/2007. PATIENT HAD CONTACTED HER PCP WHO ADVISED HER NOT TO CONTINUE THE SERIES.
(1)After two days of the second shot following symptoms happened- swollen arms and severe muscle ace and tiredness (2) After the second shot, the menstruation symptoms and routines changed with  increased blood amount (3) After the second shot the gum inflammation became severe with the pain.
Had reaction to first shot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had reaction to first shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Had reaction to first shot). At the time of the report, VACCINATION COMPLICATION (Had reaction to first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessment. No concomitant medications were reported. Treatment information was not provided.   This case was linked to MOD-2021-060125 (Patient Link).
Terrible swelling at injection site, warm to the touch, fever, rash around injection site. Swelling lasted for 2 weeks. A bump at injection site lasted 2 months.
fever 104.1, sz generalized, 1min bilat OM;rx rocephin;amoxil;
Tested positive for COVID 19; Hallucinating; Body aches; Fever; A spontaneous report was received from a consumer concerning a 62 year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and developed body aches (myalgia), fever (pyrexia), hallucinating (hallucination) and tested positive for covid 19 (SARS-CoV-2 test positive).  The patient's medical history was not reported. Concomitant product use was not reported.  On 04 Mar 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) intramuscularly in left arm for prophylaxis of COVID-19 infection.   On 06 Mar 2021, approximately 2 days after receiving vaccine, the patient developed body aches, fever and hallucinating. On 07 Mar 2021, the patient tested positive for covid 19.  Treatment information was not reported.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the mRNA-1723 does not contain virus capable of causing infection and with the occurrence of SAR-COV-2 test positive after vaccination, is unlikely related to mRNA-1273.
Trouble breathing within 30 minutes and everyday since then continuously. I?ve had this feeling before but it went away after several months. I can breath but I feel like I?m struggling in my throat feels closed up.
Patient reported tingling in injection arm down to fingertips but no numbness or weakness. The patient denied other symptoms such as  shortness of breath or hives. Patient offered to stay past 30 minutes, but she declined and said she would like to go back to work. She agreed to come back to the station if her symptoms were worsening or changing.
PT states a history of not doing well with shots.  Once PT received the vaccine at 0915, a syncopal episode began immediately.  EMS called to the vaccination room.  EMS evaluated PT and brought him to the EMS room where he was lied down on a cot.  PT was given time to recover and stated he was feeling better after 20 minutes.
patient reported that she had an anaphylactic reaction to sulfa drugs, advised to stay at pharmacy for a 30 minute wait post injection, patient called at 2pm stating that she had been having a severe headache, drowsiness, and weakness making it difficult to walk.  Advised patient to call 911 and/or seek emergency medical care if they continued to feel this way.
Left deltoid area is tender to touch, weak when lifting, painful with lifting objects and movement of arm that involves lifting of the arm.; Left deltoid area is tender to touch, weak when lifting, painful with lifting objects and movement of arm that involves lifting of the arm.; Left deltoid area is tender to touch, weak when lifting, painful with lifting objects and movement of arm that involves lifting of the arm.; This is a spontaneous report from a contactable nurse (patient) reported that a 35-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), intramuscular on the left arm on 21Dec2020 at single dose for COVID-19 immunization. The patient medical history was reported as none. The patient was not pregnant. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), escitalopram oxalate (LEXAPRO), valacyclovir, fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) and cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); all were taken from unspecified dates for unspecified indications. On 01Jan2021, it was reported that the patient's left deltoid area is tender to touch, weak when lifting, painful with lifting objects and movement of arm that involves lifting of the arm. The outcome of the events was not recovered. No therapeutic measures were taken as result of the reported events.   No follow-up attempts are possible; information about lot number was already obtained.
TINGLING SENSATION ON LEFT SIDE OF BODY; BODY NUMBNESS; INCREASED HEART RATE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, and expiry: UNKNOWN) dose was not reported, administered on right arm on 13-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 13-MAR-2021, the subject experienced tingling sensation on left side of body. On 13-MAR-2021, the subject experienced body numbness. On 13-MAR-2021, the subject experienced increased heart rate. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from body numbness, and had not recovered from increased heart rate, and tingling sensation on left side of body. This report was non-serious.; Sender's Comments: MAC Comment: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
My wife and I both recently had a meal with asparagus. Historically we both detect an odor in our urine shortly after consuming asparagus. Neither of us no longer detect this odor after eating asparagus.
The patient received vaccine that had went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 26 Feb 2022; The patient received vaccine past its 30 days of an expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient received vaccine past its 30 days of an expiry date) and PRODUCT STORAGE ERROR (The patient received vaccine that had went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 26 Feb 2022) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2022 at 1:51 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 31-Jan-2022 at 1:51 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient received vaccine past its 30 days of an expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The patient received vaccine that had went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 26 Feb 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient received vaccine past its 30 days of an expiry date) and PRODUCT STORAGE ERROR (The patient received vaccine that had went into 2-8 C thaw state on or about 24-Dec-2021 and administered on 26 Feb 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had received the vaccine dose number as booster.  No Concomitant medication reported.  It was reported that a series of approximately 540 patients had received lot 066H21A past its 30 days of an expiry date. The vaccine was administered up until its manufactured expiry date of 04-Apr-2022 and this lot number was no longer possessed.  No Treatment medication was reported.
Rash, severe itching in head, face, joints, back, extremities, and eyes. Swelling on the face , hands, feet, and joints
Brain fog began 7/23/2021, followed by short term memory loss and fatigue in the following days. On 7/26/2021, right cheek began to have pins and needles feeling, followed by same feeling in gums on right side and on tongue. By 7/27/2021, lost taste on majority of tongue, pins and needles/ numbness sensations have continued. Diagnosed with Bells Palsy 8/2/2021.
Moderna COVID-19 Vaccine EUA Freezing cold, headache, arm swollen & hurt, fever, dizzy, Memory loss, chest pain, fatigue.  No treatment.  These symptoms lasted 4 days.  (not all at once)
This spontaneous report as received from a healthcare worker refers to a 74 year old male patient. The patient had no known drug reactions/allergies. On 09-JAN-2014, the patient was vaccinated with a dose of ZOSTAVAX (lot#, expire date, route, strength dose and indication not reported). Concomitant therapies included COUMADIN. The healthcare worker reported that the patient called the pharmacy today (on 15-JAN-2014) with "questions regarding ZOSTAVAX" and "in passing stated that he has a rash". The healthcare worker could not provide details of the rash and she did not know if the rash was related to the ZOSTAVAX administration. The healthcare worker did not know the location of the rash and also stated that "he may have had the rash prior to the administration of ZOSTAVAX." At the time of reporting, the outcome of the rash was not recovered. Additional information has been requested.